Moll U - Search Results

1

M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.

Zucker S, Lysik RM, Zarrabi MH, Moll U. Zucker S, et al. Among authors: moll u. Cancer Res. 1993 Jan 1;53(1):140-6. Cancer Res. 1993. PMID: 8416738

2

Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells.

Zucker S, Moll UM, Lysik RM, DiMassimo EI, Schwedes JW, Liotta LA. Zucker S, et al. Among authors: moll um. Matrix Suppl. 1992;1:411. Matrix Suppl. 1992. PMID: 1480078 No abstract available.

3

Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells.

Zucker S, Moll UM, Lysik RM, DiMassimo EI, Stetler-Stevenson WG, Liotta LA, Schwedes JW. Zucker S, et al. Among authors: moll um. Int J Cancer. 1990 Jun 15;45(6):1137-42. doi: 10.1002/ijc.2910450625. Int J Cancer. 1990. PMID: 2161801

4

Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line.

Moll UM, Lane B, Zucker S, Suzuki K, Nagase H. Moll UM, et al. Cancer Res. 1990 Nov 1;50(21):6995-7002. Cancer Res. 1990. PMID: 2170014

5

Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.

Zucker S, Lysik RM, DiMassimo BI, Zarrabi HM, Moll UM, Grimson R, Tickle SP, Docherty AJ. Zucker S, et al. Among authors: moll um. Cancer. 1995 Aug 15;76(4):700-8. doi: 10.1002/1097-0142(19950815)76:4<700::aid-cncr2820760426>3.0.co;2-5. Cancer. 1995. PMID: 8625169

6

Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment.

Zucker S, Lysik RM, Zarrabi HM, Moll U, Tickle SP, Stetler-Stevenson W, Baker TS, Docherty AJ. Zucker S, et al. Among authors: moll u. Ann N Y Acad Sci. 1994 Sep 6;732:248-62. doi: 10.1111/j.1749-6632.1994.tb24740.x. Ann N Y Acad Sci. 1994. PMID: 7978797 Review. No abstract available.

7

Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.

Zaika AI, Kovalev S, Marchenko ND, Moll UM. Zaika AI, et al. Among authors: moll um. Cancer Res. 1999 Jul 1;59(13):3257-63. Cancer Res. 1999. PMID: 10397274

8

Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.

Moll UM, Youngleib GL, Rosinski KB, Quigley JP. Moll UM, et al. Cancer Res. 1990 Oct 1;50(19):6162-70. Cancer Res. 1990. PMID: 2169335

9

Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody.

Ramos-DeSimone N, Moll UM, Quigley JP, French DL. Ramos-DeSimone N, et al. Among authors: moll um. Hybridoma. 1993 Aug;12(4):349-63. doi: 10.1089/hyb.1993.12.349. Hybridoma. 1993. PMID: 8244415

10

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM. Concin N, et al. Cancer Res. 2004 Apr 1;64(7):2449-60. doi: 10.1158/0008-5472.can-03-1060. Cancer Res. 2004. PMID: 15059898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters